You are here

Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
West Los Angeles VA Healthcare, Pulmonary Hypertension Program
Los Angeles, California, 90073 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pulmonary Arterial Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects aged 18 and over above with PAH and for which bosentan therapy is indicated
according to national license

- Subjects with a mean pulmonary artery pressure of >25mmHg and a pulmonary artery wedge
pressure of randomization.

- Subjects whose baseline 6 Minute Walk Test distance is >100m and

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- PAH secondary to any aetiology including congenital heart disease other than those
specified in the inclusion criteria

- Subjects whose 6 Minute Walk Test may be limited by conditions other than PAH related
dyspnoea or fatigue eg. claudication from vascular insufficiency or arthritis.

NCT00323297
Pfizer
Completed
Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Pulmonary Arterial Hypertension
NCT03364244
All Genders
0+
Years
Tokyo,
Pulmonary Arterial Hypertension, Pulmonary Hypertension
NCT00795639
All Genders
16+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now